Therefore, we first analyzed a 17-year observational data from Taiwan National Health Insurance Research Database to explore whether DPP4 inhibitor could inhibit chronic PD-induced peritoneal fibrosis and further reduce the rate of PD failure. This evidence concerns the gene DPP4 and Peritoneal Fibrosis.